$4.46B
$751,000
0.0% of portfolio
2,224
Q3 2024
Reduced 6.71%
$0
$11,000
0.0% of portfolio
140,000
Q1 2022
New
$304K
$0
0.0% of portfolio
70,000
Q1 2022
New
$1.23B
$1.72 Million
0.0% of portfolio
23,707
Q3 2024
Added 11.75%
$215M
$1.04 Million
0.0% of portfolio
89,929
Q3 2024
Reduced 10.13%
Kandi Technologies Group Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 12.78%
$57.5M
$869,000
0.0% of portfolio
1,047,396
Q3 2024
Added 24.08%
$23.5B
$834,000
0.0% of portfolio
13,522
Q3 2024
Reduced 74.96%
$6.29B
$1.34 Million
0.0% of portfolio
15,690
Q3 2024
Reduced 95.41%
$557M
$1.41 Million
0.0% of portfolio
205,203
Q3 2024
Reduced 55.88%
Keen Vision Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2023
New
Keen Vision Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2023
New
$27.5B
$4.51 Million
0.0% of portfolio
55,859
Q3 2024
Reduced 97.03%
$480M
$1.12 Million
0.0% of portfolio
52,539
Q3 2024
Added 3.77%
$4.32B
$4.39 Million
0.0% of portfolio
71,754
Q3 2024
Added 106.73%
$2.2B
$3.53 Million
0.0% of portfolio
135,862
Q3 2024
Reduced 71.79%
$1.54B
$385,000
0.0% of portfolio
34,812
Q3 2024
Reduced 80.0%
$1.26B
$1.37 Million
0.0% of portfolio
22,247
Q3 2024
Added 328.9%
$4.82B
$418,000
0.0% of portfolio
10,814
Q3 2024
Reduced 98.38%
$474M
$1.96 Million
0.0% of portfolio
105,859
Q3 2024
Reduced 3.78%
Kiniksa Pharmaceuticals Intl
-
$0
0.0% of portfolio
-
Q3 2024
Added 89.21%
$13.1B
$3.91 Million
0.0% of portfolio
416,998
Q3 2024
Reduced 56.05%
$5.76B
$2.49 Million
0.0% of portfolio
93,891
Q3 2024
Reduced 21.92%
$792M
$3.48 Million
0.0% of portfolio
281,754
Q3 2024
Reduced 4.82%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 50.76%
$436M
$2.4 Million
0.0% of portfolio
918,760
Q3 2024
Reduced 2.79%
$1.65B
$1.21 Million
0.0% of portfolio
57,138
Q3 2024
Reduced 26.6%
$4.94B
$2.46 Million
0.0% of portfolio
30,090
Q3 2024
Reduced 81.4%
$706M
$335,000
0.0% of portfolio
9,173
Q3 2024
Added 22.98%
$9.48B
$339,000
0.0% of portfolio
43,746
Q3 2024
Added 187.61%
$1.44B
$60,000
0.0% of portfolio
15,000
Q3 2024
New
$1.69B
$744,000
0.0% of portfolio
69,274
Q3 2024
New
$4.45B
$1.7 Million
0.0% of portfolio
9,346
Q3 2024
Reduced 15.39%
$42.9B
$1.39 Million
0.0% of portfolio
5,841
Q3 2024
Reduced 36.79%
$1.9B
$1.8 Million
0.0% of portfolio
41,900
Q3 2024
Reduced 78.47%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 13.36%
$1.52B
$1.76 Million
0.0% of portfolio
151,311
Q3 2024
Reduced 45.99%
$1.85B
$535,000
0.0% of portfolio
8,223
Q3 2024
Added 10.87%
Lakeshore Biopharma CO LTD
-
$0
0.0% of portfolio
-
Q1 2023
New
$439M
$2.07 Million
0.0% of portfolio
155,988
Q3 2024
Reduced 7.99%
$6.72B
$3 Million
0.0% of portfolio
15,881
Q3 2024
Added 7.37%
$6.32B
$251,000
0.0% of portfolio
2,291
Q3 2024
Reduced 92.72%
Lanvin Group Holdings Limite
-
$0
0.0% of portfolio
-
Q4 2022
New
$266M
$105,000
0.0% of portfolio
16,122
Q3 2024
New
$8.58B
$5.04 Million
0.0% of portfolio
94,835
Q3 2024
Added 25.81%
Launch One Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
$3.15B
$869,000
0.0% of portfolio
52,372
Q3 2024
Reduced 26.1%
-
$0
0.0% of portfolio
-
Q3 2024
Added 47.14%